You are here: Industry Insights > linagliptin

News List

Zydus Cadila gets tentative USFDA nod for empagliflozin and linagliptin tablets expresspharma
September 18, 2020
They are oral diabetes medicines that help control blood sugar levels.
Lupin receives US FDA’s tentative approval for Empagliflozin and Linagliptin Tablets expresspharma
July 24, 2020
Empagliflozin and Linagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Turbulent Patterns of DPP-4 Inhibitor Hypoglycemics: First Generic of Linagliptin Approved and a New Manufacturer Approved to Market Vildagliptin PharmaSources/Miling
July 22, 2020
Guangdong HEC Pharmaceutical’s Class 4 generic drug: Linagliptin Tablets and Nanjing Sanhome Pharmaceutical’s Class 4 generic drug.
Linagliptin demonstrates cardiovascular and renal safety in Asian adults with type 2 diabetes expresspharma
July 01, 2020
In a sub-analysis of the CAROLINA cardiovascular outcome trial, linagliptin demonstrated no increased cardiovascular risk versus glimepiride in Asian adults with type 2 diabetes and high cardiovascular risk.
Linagliptin Noninferior for CV Risk in Early Type 2 Diabetes drugs
September 20, 2019
According to a study published online Sept. 19 in the Journal of the American Medical Association to coincide with the annual meeting of the European Association for the Study of Diabetes ...